Moleculin Biotech Inc (MBRX)
4.77
+0.13
(+2.80%)
USD |
NASDAQ |
May 31, 16:00
4.78
+0.01
(+0.21%)
After-Hours: 20:00
Moleculin Biotech Price to Book Value: 0.5108 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 0.5108 |
| May 30, 2024 | 0.4968 |
| May 29, 2024 | 0.4733 |
| May 28, 2024 | 0.4904 |
| May 24, 2024 | 0.5279 |
| May 23, 2024 | 0.5515 |
| May 22, 2024 | 0.544 |
| May 21, 2024 | 0.5311 |
| May 20, 2024 | 0.53 |
| May 17, 2024 | 0.544 |
| May 16, 2024 | 0.5386 |
| May 15, 2024 | 0.5268 |
| May 14, 2024 | 0.5193 |
| May 13, 2024 | 0.5001 |
| May 10, 2024 | 0.5097 |
| May 09, 2024 | 0.5118 |
| May 08, 2024 | 0.5033 |
| May 07, 2024 | 0.545 |
| May 06, 2024 | 0.5397 |
| May 03, 2024 | 0.5375 |
| May 02, 2024 | 0.5515 |
| May 01, 2024 | 0.5418 |
| April 30, 2024 | 0.5375 |
| April 29, 2024 | 0.5365 |
| April 26, 2024 | 0.4958 |
| Date | Value |
|---|---|
| April 25, 2024 | 0.4613 |
| April 24, 2024 | 0.4658 |
| April 23, 2024 | 0.4926 |
| April 22, 2024 | 0.4604 |
| April 19, 2024 | 0.4979 |
| April 18, 2024 | 0.4844 |
| April 17, 2024 | 0.4583 |
| April 16, 2024 | 0.4583 |
| April 15, 2024 | 0.4776 |
| April 12, 2024 | 0.4954 |
| April 11, 2024 | 0.5108 |
| April 10, 2024 | 0.5568 |
| April 09, 2024 | 0.56 |
| April 08, 2024 | 0.5407 |
| April 05, 2024 | 0.5568 |
| April 04, 2024 | 0.5675 |
| April 03, 2024 | 0.5622 |
| April 02, 2024 | 0.5836 |
| April 01, 2024 | 0.6071 |
| March 28, 2024 | 0.5049 |
| March 27, 2024 | 0.4733 |
| March 26, 2024 | 0.3998 |
| March 25, 2024 | 0.4485 |
| March 22, 2024 | 0.4874 |
| March 21, 2024 | 0.5664 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2828
Minimum
Sep 20 2023
8.801
Maximum
Feb 10 2021
1.687
Average
0.8639
Median
Mar 08 2024
Price to Book Value Benchmarks
| Merck & Co Inc | 7.878 |
| Lixte Biotechnology Holdings Inc | -- |
| Moderna Inc | 4.262 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 18.40 |
Price to Book Value Related Metrics
| Price | 4.77 |
| Earnings Yield | -275.0% |
| Market Cap | 11.03M |